Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2004;109:544-549
Published online before print January 26, 2004, doi: 10.1161/01.CIR.0000109701.77059.E9
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
109/4/544    most recent
01.CIR.0000109701.77059.E9v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Shiomi, T.
Right arrow Articles by Takeshita, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Shiomi, T.
Right arrow Articles by Takeshita, A.
Related Collections
Right arrow Structure
Right arrow Congestive
Right arrow Remodeling
Right arrow Animal models of human disease
Right arrow Apoptosis
Right arrow Genetically altered mice
Right arrow Heart failure - basic studies
Right arrow Oxidant stress

(Circulation. 2004;109:544-549.)
© 2004 American Heart Association, Inc.


Basic Science Reports

Overexpression of Glutathione Peroxidase Prevents Left Ventricular Remodeling and Failure After Myocardial Infarction in Mice

Tetsuya Shiomi, MD; Hiroyuki Tsutsui, MD; Hidenori Matsusaka, MD; Kimiyo Murakami, MS; Shunji Hayashidani, MD; Masaki Ikeuchi, MD; Jing Wen, MD; Toru Kubota, MD; Hideo Utsumi, PhD; Akira Takeshita, MD

From the Department of Cardiovascular Medicine, Graduate School of Medical Sciences (T.S., H.T., H.M., S.H., M.I., J.W., T.K., A.T.), and Department of Biophysics, Graduate School of Pharmaceutical Sciences (K.M., H.U.), Kyushu University, Fukuoka, Japan.

Correspondence to Hiroyuki Tsutsui, MD, PhD, Department of Cardiovascular Medicine, Graduate School of Medical Sciences, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka, 812-8582, Japan. E-mail prehiro{at}cardiol.med.kyushu-u.ac.jp

Received June 10, 2003; de novo received August 11, 2003; revision received September 23, 2003; accepted September 25, 2003.

Background— Oxidative stress plays an important role in the pathophysiology of heart failure. We determined whether the overexpression of glutathione peroxidase (GSHPx) could attenuate left ventricular (LV) remodeling and failure after myocardial infarction (MI).

Methods and Results— We created MI in 12- to 16-week-old, male GSHPx transgenic mice (TG+MI) and nontransgenic wild-type littermates (WT+MI) by ligating the left coronary artery. GSHPx activity was increased in the hearts of TG mice, with no significant changes in other antioxidant enzymes. LV concentrations of thiobarbituric acid–reactive substances measured in TG+MI at 4 weeks were significantly lower than those in WT+MI. The survival rate during 4 weeks of MI was significantly higher in TG+MI than in WT+MI, although the infarct size was comparable. LV cavity dilatation and dysfunction were significantly attenuated in TG+MI. LV end-diastolic pressure was increased in WT+MI and reduced in TG+MI. Improvement of LV function in TG+MI was accompanied by a decrease in myocyte hypertrophy, apoptosis, and interstitial fibrosis in the noninfarcted LV. Myocardial matrix metalloproteinase-9 zymographic and protein levels were increased in WT+MI after 3 days but were attenuated in TG+MI.

Conclusions— Overexpression of GSHPx inhibited LV remodeling and failure after MI. Therapies designed to interfere with oxidative stress might be beneficial to prevent cardiac failure.


Key Words: myocardial infarction • heart failure • remodeling • antioxidants • free radicals




This article has been cited by other articles:


Home page
EndocrinologyHome page
A. Pedram, M. Razandi, D. Lubahn, J. Liu, M. Vannan, and E. R. Levin
Estrogen Inhibits Cardiac Hypertrophy: Role of Estrogen Receptor-{beta} to Inhibit Calcineurin
Endocrinology, July 1, 2008; 149(7): 3361 - 3369.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
C. G. Tankersley, H. C. Champion, E. Takimoto, K. Gabrielson, D. Bedja, V. Misra, H. El-Haddad, R. Rabold, and W. Mitzner
Exposure to inhaled particulate matter impairs cardiac function in senescent mice
Am J Physiol Regulatory Integrative Comp Physiol, July 1, 2008; 295(1): R252 - R263.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
T. Tsutsumi, T. Ide, M. Yamato, W. Kudou, M. Andou, Y. Hirooka, H. Utsumi, H. Tsutsui, and K. Sunagawa
Modulation of the myocardial redox state by vagal nerve stimulation after experimental myocardial infarction
Cardiovasc Res, March 1, 2008; 77(4): 713 - 721.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
Y. H. Looi, D. J. Grieve, A. Siva, S. J. Walker, N. Anilkumar, A. C. Cave, M. Marber, M. J. Monaghan, and A. M. Shah
Involvement of Nox2 NADPH Oxidase in Adverse Cardiac Remodeling After Myocardial Infarction
Hypertension, February 1, 2008; 51(2): 319 - 325.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
A. R. Hemnes, A. Zaiman, and H. C. Champion
PDE5A inhibition attenuates bleomycin-induced pulmonary fibrosis and pulmonary hypertension through inhibition of ROS generation and RhoA/Rho kinase activation
Am J Physiol Lung Cell Mol Physiol, January 1, 2008; 294(1): L24 - L33.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
D. Juric, P. Wojciechowski, D. K. Das, and T. Netticadan
Prevention of concentric hypertrophy and diastolic impairment in aortic-banded rats treated with resveratrol
Am J Physiol Heart Circ Physiol, May 1, 2007; 292(5): H2138 - H2143.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
P. Zhang, X. Xu, X. Hu, E. D. van Deel, G. Zhu, and Y. Chen
Inducible Nitric Oxide Synthase Deficiency Protects the Heart From Systolic Overload-Induced Ventricular Hypertrophy and Congestive Heart Failure
Circ. Res., April 13, 2007; 100(7): 1089 - 1098.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
M. Torzewski, V. Ochsenhirt, A. L. Kleschyov, M. Oelze, A. Daiber, H. Li, H. Rossmann, S. Tsimikas, K. Reifenberg, F. Cheng, et al.
Deficiency of Glutathione Peroxidase-1 Accelerates the Progression of Atherosclerosis in Apolipoprotein E-Deficient Mice
Arterioscler. Thromb. Vasc. Biol., April 1, 2007; 27(4): 850 - 857.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
E. Takimoto and D. A. Kass
Role of Oxidative Stress in Cardiac Hypertrophy and Remodeling
Hypertension, February 1, 2007; 49(2): 241 - 248.
[Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
S. Matsushima, S. Kinugawa, T. Ide, H. Matsusaka, N. Inoue, Y. Ohta, T. Yokota, K. Sunagawa, and H. Tsutsui
Overexpression of glutathione peroxidase attenuates myocardial remodeling and preserves diastolic function in diabetic heart
Am J Physiol Heart Circ Physiol, November 1, 2006; 291(5): H2237 - H2245.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
S. Kawano, T. Kubota, Y. Monden, T. Tsutsumi, T. Inoue, N. Kawamura, H. Tsutsui, and K. Sunagawa
Blockade of NF-{kappa}B improves cardiac function and survival after myocardial infarction
Am J Physiol Heart Circ Physiol, September 1, 2006; 291(3): H1337 - H1344.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
C. E. Murdoch, M. Zhang, A. C. Cave, and A. M. Shah
NADPH oxidase-dependent redox signalling in cardiac hypertrophy, remodelling and failure
Cardiovasc Res, July 15, 2006; 71(2): 208 - 215.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
S. Matsushima, T. Ide, M. Yamato, H. Matsusaka, F. Hattori, M. Ikeuchi, T. Kubota, K. Sunagawa, Y. Hasegawa, T. Kurihara, et al.
Overexpression of Mitochondrial Peroxiredoxin-3 Prevents Left Ventricular Remodeling and Failure After Myocardial Infarction in Mice
Circulation, April 11, 2006; 113(14): 1779 - 1786.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
M. Morihira, N. Hasebe, E. Baljinnyam, K. Sumitomo, T. Matsusaka, K. Izawa, T. Fujino, J. Fukuzawa, and K. Kikuchi
Ischemic preconditioning enhances scavenging activity of reactive oxygen species and diminishes transmural difference of infarct size
Am J Physiol Heart Circ Physiol, February 1, 2006; 290(2): H577 - H583.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
R. M. Saraiva, K. M. Minhas, S. V.Y. Raju, L. A. Barouch, E. Pitz, K. H. Schuleri, K. Vandegaer, D. Li, and J. M. Hare
Deficiency of Neuronal Nitric Oxide Synthase Increases Mortality and Cardiac Remodeling After Myocardial Infarction: Role of Nitroso-Redox Equilibrium
Circulation, November 29, 2005; 112(22): 3415 - 3422.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
M. Ikeuchi, H. Matsusaka, D. Kang, S. Matsushima, T. Ide, T. Kubota, T. Fujiwara, N. Hamasaki, A. Takeshita, K. Sunagawa, et al.
Overexpression of Mitochondrial Transcription Factor A Ameliorates Mitochondrial Deficiencies and Cardiac Failure After Myocardial Infarction
Circulation, August 2, 2005; 112(5): 683 - 690.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
J. A. Leopold and J. Loscalzo
Oxidative Enzymopathies and Vascular Disease
Arterioscler. Thromb. Vasc. Biol., July 1, 2005; 25(7): 1332 - 1340.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
M. Ikeuchi, H. Tsutsui, T. Shiomi, H. Matsusaka, S. Matsushima, J. Wen, T. Kubota, and A. Takeshita
Inhibition of TGF-{beta} signaling exacerbates early cardiac dysfunction but prevents late remodeling after infarction
Cardiovasc Res, December 1, 2004; 64(3): 526 - 535.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
G. F. Tomaselli and D. P. Zipes
What Causes Sudden Death in Heart Failure?
Circ. Res., October 15, 2004; 95(8): 754 - 763.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
M. Bourraindeloup, C. Adamy, G. Candiani, M. Cailleret, M.-C. Bourin, T. Badoual, J. B. Su, S. Adubeiro, F. Roudot-Thoraval, J.-L. Dubois-Rande, et al.
N-Acetylcysteine Treatment Normalizes Serum Tumor Necrosis Factor-{alpha} Level and Hinders the Progression of Cardiac Injury in Hypertensive Rats
Circulation, October 5, 2004; 110(14): 2003 - 2009.
[Abstract] [Full Text] [PDF]